The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study
-
Zijlstra, Josée M. (Amsterdam UMC)
;
Follows, George (Cambridge University Hospitals NHS Foundation Trust (Regne Unit)) ;
Casasnovas, Rene-Olivier (University Hospital F. Mitterrand) ;
Vermaat, Joost S. P. (Leiden University Medical Center) ;
Kalakonda, Nagesh (University of Liverpool) ;
Choquet, Sylvain (Hôpital Pitié Salpêtrière) ;
Hill, Brian (Taussig Cancer Institute) ;
Thieblemont, Catherine (Saint-Louis Hospital) ;
Cavallo, Federica (University of Torino/AOU) ;
la Cruz, Fatima De (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Kuruvilla, John (Princess Margaret Cancer Centre) ;
Hamad, Nada (University of Notre Dame Australia) ;
Jaeger, Ulrich (Medical University of Vienna) ;
Caimi, Paolo (Case Western Reserve University) ;
Gurion, Ronit (Rabin Medical Center) ;
Warzocha, Krzysztof (Instytut Hematologii I Transfuzjologii) ;
Bakhshi, Sameer (All India Institute of Medical Sciences (Nova Delhi, Índia)) ;
Sancho, Juan-Manuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Schuster, Michael (Stony Brook University Hospital) ;
Egyed, Miklos (Teaching Hospital Mór Kaposi) ;
Offner, Fritz (Ghent University Hospital (Bèlgica)) ;
Vassilakopoulos, Theodoros P. (National and Kapodistrian University of Athens) ;
Samal, Priyanka (Institute of Medical Sciences & SUM Hospital) ;
Ku, Matthew (St Vincent's Hospital (Sydney)) ;
Xu, Jenny (Karyopharm Therapeutics) ;
Corona, Kelly (Karyopharm Therapeutics) ;
Chamoun, Kamal (Karyopharm Therapeutics) ;
Shah, Jatin (Karyopharm Therapeutics) ;
Canales, Miguel (Hospital Universitario La Paz (Madrid)) ;
Maerevoet, Marie (Institut Jules Bordet) ;
Universitat Autònoma de Barcelona
guest ::
Subscribe to this discussion. You will then receive all new comments by email.
